This study is dedicated to the comparative analysis of interleukin 1 and interleukin 18 levels in the blood serum of the patients of elderly and old age with helicobacter pylori-positive and helicobacter pylori-negative peptic ulcers.
peptic ulcer, interleukins, helicobacter pylori infection, inflammasome, patients of elderly and old age
1. Lee S.P., Sung I.K., Kim J.H. et al. Risk Factors for the Presence of Symptoms in Peptic Ulcer Disease // Clin Endosc. – 2017 Nov; 50(6):578–584. Doi:https://doi.org/10.5946/ce.2016.129
2. Idris M., Smiley A., Patel S. et al. Risk Factors for Mortality in Emergently Admitted Patients with Acute Gastric Ulcer: An Analysis of 15,538 Patients in National Inpatient Sample, 2005–2014. Int. J. Envirol. Res. // Public Health. – 2022, 19, 16263. Doi:https://doi.org/10.3390/ijerph192316263
3. Pakirdinov A.S., Madazimov M.M., Abdukadirov D.A. et al. Features of gastric and duodenal ulcers in elderly patients // World Bulletin of Public Health (WBPH). – 2022; 13. https: //scholarexpress.net/index.php/wbph/article/view/1244
4. Thorsen K., Søreide J.A., Kvaløy J.T. et al. Epidemiology of perforated peptic ulcer: Age- and gender-adjusted analysis of incidence and mortality // World J Gastroenterol – 2013; 19(3): 347–354. Doi:https://doi.org/10.3748/wjg.v19.i3.347
5. Shen Q., Sun Z.H., Xu Y.M. et al. Associations between complete-blood-count-derived inflammatory markers and gastric ulcer: A cross-sectional study // World J Gastroenterol. – 2025 Oct 14; 31(38):111298. Doi:https://doi.org/10.3748/wjg.v31.i38.111298
6. Ganjali A., Fakheri B.A., Bahari A. et al. The role of cytokines and pattern recognition receptors in inflammation caused by helicobacter pylori infection in gastric cancer // Int J Basic Sci Med. – 2022; 7(1):3–10. Doi: 10.34172/ ijbms.2022.02
7. Fei X., Chen S., Li L., Xu X. et al. Helicobacter pylori infection promotes M1 macrophage polarization and gastric inflammation by activation of NLRP3 inflammasome via TNF/TNFR1 axis // Cell Commun Signal. – 2025 Jan 6; 23(1):6. Doi:https://doi.org/10.1186/s12964-024-02017-7
8. Skokowski J., Vashist Y., Girnyi S. et al. The Aging Stomach: Clinical Implications of H. pylori Infection in Older Adults-Challenges and Strategies for Improved Management // Int J Mol Sci. – 2024 Nov 28; 25(23):12826. Doi:https://doi.org/10.3390/ijms252312826
9. Chen Z.-M., Li W.-F., Yu X.-Q., Tang X., Yang Q.-H., Wei X.-L. Research progress on hyperbaric oxygen therapy for refractory peptic ulcer disease // Front. Med. – 2025; 12:1708973. Doi:https://doi.org/10.3389/fmed.2025.1708973
10. Ivashkin V.T., Maev I.V., Car'kov P.V. i soavt. Diagnostika i lechenie yazvennoy bolezni u vzroslyh (Klinicheskie rekomendacii Rossiyskoy gastroenterologicheskoy associacii, Rossiyskogo obschestva kolorektal'nyh hirurgov, Rossiyskogo endoskopicheskogo obschestva i Nauchnogo soobschestva po sodeystviyu klinicheskomu izucheniyu mikrobioma cheloveka) // Rossiy- skiy zhurnal gastroenterologii, gepatologii, koloproktologii. – 2024; 34(2):101–131. Doi:https://doi.org/10.22416/1382-4376-2024-34-2-101-131
11. Hicks C.L., von Baeyer C.L., Spafford P.A. et al. The Faces Pain Scale-Revised: toward a common metric in pediatric pain measurement // Pain. – 2001 Aug; 93(2):173–183. Doi:https://doi.org/10.1016/S0304-3959(01)00314-1
12. Karateev A.E., Lila A.M., Mazurov V.I. i soavt. Konsensus ekspertov 2024: racional'- noe ispol'zovanie nesteroidnyh protivovospa litel'nyh preparatov // Sovremennaya revmato- logiya. – 2025; 19 (Pril. 1):1–40. Doi:https://doi.org/10.14412/1996-7012-2025-1S-1-40 2
13. Kumar S., Dhiman M. Helicobacter pylori secretary Proteins-Induced oxidative stress and its role in NLRP3 inflammasome activation // Cell Immunol. – 2024 May-Jun; 399-400:104811. Doi:https://doi.org/10.1016/j.cellimm.2024.104811
14. Yu Q., Shi H., Ding Z. et al. The E3 ubiquitin ligase TRIM31 attenuates NLRP3 inflammasome activation in Helicobacter pylori-associated gastritis by regulating ROS and autophagy // Cell Commun Signal. – 2023 Jan 3; 21(1):1. Doi:https://doi.org/10.1186/s12964-022-00954-9
15. Laraib I., Qasim S., Uttra A.M. et al. Anti-Inflammatory, Antihyperalgesic, and Gastric Safety Profiling of Ocimene: Attenuation of Nonsteroidal Anti-Inflammatory Drug-Induced Gastric Ulcers by Modulating Toll-like Receptor 4 and Pyroptosis Pathways // ACS Pharmacol Transl Sci. – 2025 Feb 14; 8(3):748–761. Doi:https://doi.org/10.1021/acsptsci.4c00639
16. Blevins H.M., Xu Y., Biby S. et al. The NLRP3 Inflammasome Pathway: A Review of Mechanisms and Inhibitors for the Treatment of Inflammatory Diseases // Front Aging Neurosci. – 2022 Jun 10; 14:879021. Doi:https://doi.org/10.3389/fnagi.2022.879021
17. Zabaleta J., Camargo M.C., Ritchie M.D. et al. Association of haplotypes of inflammation- related genes with gastric preneoplastic lesions in African Americans and Caucasians // Int J Cancer. – 2011 Feb 1; 128(3):668-75. Doi:https://doi.org/10.1002/ijc.25385
18. Dong-Hyun Kim, Gona Choi, Eun-Bi Song et al. Treatment of IL-18-binding protein biologics suppresses fibrotic progression in metabolic dysfunction-associated steatohepatitis // Cell Reports Medicine. – 2025; 6(4): 102047. Doi:https://doi.org/10.1016/j.xcrm.2025.102047
19. Wallace J.L. Prostaglandins, NSAIDs and Gastric Mucosal Protection: Why Doesn't the Stomach Digest Itself? // Physiol Rev. – 2019; 99(4):1977–2016. Doi:https://doi.org/10.1152/physrev.00030.2018
20. Melcarne L., García-Iglesias P., Calvet X. Management of NSAID-associated peptic ulcer disease // Expert Rev Gastroenterol Hepatol. – 2016 Jun; 10(6):723–33. Doi:https://doi.org/10.1586/17474124.2016.1142872
